Skip to content

Effect of infusion of esketamine on postoperative delirium in elderly patients in the intensive care unit

Effect of short infusion of low-dose esketamine on postoperative delirium in elderly frail patients in the intensive care unit

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077940
Enrollment
Unknown
Registered
2023-11-24
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Test group:The test group received low-dose esketamine short infusion treatment.
Control group:The control group received placebo (saline) short infusion therapy.

Sponsors

Affiliated Hospital of Jiaxing University(The First Hospital of Jiaxing )
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 96 Years

Inclusion criteria

Inclusion criteria: Elderly patients undergoing noncardiac surgery under general anesthesia and transferred to the postanesthesia care unit (AICU) postoperatively, aged =65 years, of either sex, with ASA classification I-III, and a preoperative Fried Frailty Scale score of =3.

Exclusion criteria

Exclusion criteria: (i) preoperative delirium and cognitive dysfunction; (ii) preoperative central nervous system disease, psychiatric abnormalities or psychological disorders; (iii) patients with stroke or craniocerebral surgery; (iv) inability to complete neuropsychiatric function measurements prior to surgery; (v) allergy to or contraindication to esketamine and other study-related drugs; (vi) severe abnormalities of liver and renal function; (vii) previous history of PND; and (viii) those who refused to participate in the study.

Design outcomes

Primary

MeasureTime frame
Occurrence of postoperative delirium;

Secondary

MeasureTime frame
Level of sedation (RASS score);sleep quality score (PSQI score);pain level (NRS score);The levels of inflammatory factors such as IL6, PCT, CRP, etc;Occurrence of adverse reactions;

Countries

China

Contacts

Public ContactDeng Kang

Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing)

jxmzdk@163.com+86 137 3644 6844

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026